GN-CORPORATION
19.10.2021 08:48:06 CEST | Business Wire | Press release
Alfred Patisenah and Daisy Ramadhani of School of Life Sciences and Technology, Indonesia, won the prestigious Fujio Cup Quiz (FCQ), an active knowledge gaining academic event of NCRM NICHE 2021, on stem cells and regenerative medicine, in a fiercely fought contest among teams representing NIMHANS, Bangalore, India and Kasturba Medical College, the defending champions. Rajalakshmi Engineering College represented by Vigneshwar Ranjan and Vasanta Vaarshini Umapathi came runners in this contest across in three stages with assignments and online live quizzing, conducted since 2006, every October to commemorate the inaugural anniversary of Nichi in Centre for Regenerative Medicine.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211018006087/en/
The virtual event had lectures by Prof. Gary Levy , founder, Training program in regenerative medicine, University of Toronto (www.regenmedcanada.com ) on lessons learnt during the pandemic and arenas of research for tackling future Covid-19 like viruses (https://www.springer.com/gp/book/9781461357759 ), Prof. Kazutoshi Mori , Kyoto University, a Lasker prize awardee (https://www.nature.com/articles/nm.3682 ) on unfolding protein response and endoplasmic reticulum stress (https://elifesciences.org/articles/60970 ) and Prof. Timothy Kieffer , University of British Columbia & CSO of Viacyte Inc., on encapsulated pancreatic islet cell transplantation for diabetes (https://doi.org/10.3389/fendo.2021.642152 ). Covid-19 related research were presented by Dr. Tomohiko Kisaka, Hiroshima University, Dr. Stanley Jeremiah, Yokohama City University (https://jamanetwork.com/journals/jama/fullarticle/2765837 ), Dr. K. Raghavan, JAICARE, Madurai, India (https://www.sciencedirect.com/science/article/pii/S0753332221010271 ), Dr. K. Ramesh Shankar, NHS Trust - Lincolnshire Partnership, London United Kingdom (https://www.jns-journal.com/article/S0022-510X(21)00248-3/fulltext ) and Dr Dedeepiya Devaprasad, who spoke on BREW-COCO method for early prediction of worsening outcome in Covid-19. Prof. Jurgen Hescheler, University of Cologne, Germany, Prof. Naoki Yamamoto, Emeritus Professor, National Centre for Global health and Medicine, Tokyo, Japan and Prof. Pushkala Subramaniam, TN MGR Medical University, India, moderated.
NCRM NICHE an inter-disciplinary event cum innovation platform, spearheading development of novel solutions for Non-alcoholic steatohepatitis (NASH or NAFLD : https://doi.org/10.1101/2021.07.08.451700 ) and for managing neurodevelopmental disorders like Autism Spectrum Disorders (https://doi.org/10.1101/2021.06.28.21259619 ), has started attracting multinational investors. Enso Healthcare DMCC, Dubai, UAE, who have partnered with GN Corporation for this active knowledge gaining academic event, being a part of Enso group, a global conglomerate with diverse interests is envisaging to develop path breaking solutions through futuristic research for prevention and management of lifestyle illnesses and in the domains of anti-aging and longevity.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211018006087/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Croma-Pharma Acquires Synocrom™ and Returns to Orthopaedics8.4.2026 07:00:00 CEST | Press release
Hyaluronic acid product for knee osteoarthritis available in the EU and Switzerland from May 2026 Croma-Pharma is returning to the orthopaedics market with the reacquisition of Synocrom™, a hyaluronic acid product for the treatment of knee osteoarthritis. A strategic return built on proven heritage With the reacquisition of Synocrom™, Croma-Pharma is re-entering orthopaedics and further broadening its portfolio in a field with strong historical roots for the company. Until 2014, Croma was active in orthopaedics, with Synocrom™ serving as a key pillar of its offering. Synocrom™ is not a new name in the market. During the period in which Croma actively marketed the product, it became one of the leading hyaluronic acid brands in Europe and ranked among the top brands in its category. Its return therefore represents more than a portfolio expansion: it marks the continuation of a successful orthopaedic legacy and reconnects Croma with an important part of its history. The reintroduction of
Murata Begins Mass Production of Seven Automotive MLCCs with World-leading Capacitance for Their Rated Voltage and Size, Supporting Stable Operation of In-vehicle Systems and Greater Design Flexibility8.4.2026 04:00:00 CEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has begun mass production of seven AEC-Q200-qualified multilayer ceramic capacitors (MLCCs) that achieve the world’s largest capacitance for a given rated voltage and size*, supporting stable operation of in-vehicle systems and greater design flexibility. Five parts in the GCM series are rated at 2.5-4 Vdc, targeting IC peripheral circuits in advanced driver assistance systems (ADAS) and autonomous driving (AD) applications. The remaining two MLCCs are rated at 25 Vdc for in-vehicle power line applications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260407486750/en/ [Murata Manufacturing Co., Ltd.] Seven automotive MLCCs In recent years, as ADAS and AD technologies advance, the number and performance level of systems installed in vehicles have continued to increase. As a result, demand for higher capacitance low-voltage MLCCs used around ICs has grown to e
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)7.4.2026 22:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to seven newly hired non-executive employees. The equity awards were granted on April 1, 2026 and consisted of options to purchase an aggregate of 117,445 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 55,875 shares. The options have an exercise price per share equal to $5.62, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted s
SLB OneSubsea and Subsea7 Sign Collaboration Agreement with PETRONAS Suriname7.4.2026 22:05:00 CEST | Press release
Partnership enables early engagement to co-develop cost-effective solutions and accelerate subsea development in Suriname Global energy technology company SLB (NYSE: SLB) today announced the signing of a strategic collaboration agreement between PETRONAS Suriname E&P B.V. (“PETRONAS Suriname”), a subsidiary of PETRONAS and Subsea Integration Alliance, comprising SLB OneSubsea and Subsea7. This partnership aims to unlock resources in Suriname’s emerging frontier basin through innovative and cost-effective subsea solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260331210557/en/ SLB OneSubsea has signed a strategic collaboration agreement between PETRONAS Suriname E&P B.V. (“PETRONAS Suriname”), a subsidiary of PETRONAS and Subsea Integration Alliance, comprising SLB OneSubsea and Subsea7. This partnership aims to unlock resources in Suriname’s emerging frontier basin through innovative and cost-effective subsea soluti
Nadia Karkar Joins 500 Global as Managing Partner7.4.2026 19:43:00 CEST | Press release
Former TPG Rise executive joins as Managing Partner as the firm expands its global investment platform. 500 Global today announced the appointment of Nadia Karkar as Managing Partner as the firm expands its global investment platform. Nadia’s appointment follows the recent announcement of the appointment of Atul Mehta — former Chief Investment Officer of the International Finance Corporation — to 500 Global's Board of Directors, and reflects the firm's continued build-out of the leadership and capabilities required to deliver on its next stage of global growth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260407719214/en/ Nadia Karkar Joins 500 Global as Managing Partner Nadia joins from TPG Rise, the $31 billion impact investing platform of TPG Inc., where she most recently served as Head of Business Development, responsible for product innovation, strategic partnerships and corporate development. She played a central rol
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom